Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study

Jul 01, 2020

The head-to-head comparison between the two point-of-care tests and HPLC showed concordance between the three testing methods in screening 313 newborn babies, with a specificity of 100% with HemoTypeSC, 100% with SickleSCAN, and 100% by HPLC, and a sensitivity of 100% with HemoTypeSC, 100% with SickleSCAN, and 100% by HPLC.The pilot study shows that the integration of newborn screening into existing primary health-care immunisation programmes is feasible and can rapidly be implemented with limited resources. Point-of-care tests are reliable and accurate in newborn screening for sickle cell disease. The Lancet Haematology


Other news

Cookies help us deliver our services. By using our services, you agree to our use of cookies. What are cookies?